Bill Text — Jan 20, 2015
This bill’s text is now available.
GovTrack Insider, our Kickstarter-backed work to summarize bills in Congress, has resumed. Here’s what we’ve been up to:
Aug 2, 2013
113th Congress, 2013–2015
This bill was introduced on August 2, 2013, in a previous session of Congress, but was not enacted.
Representative for Utah's 3rd congressional district
Read Text »
Last Updated: Aug 2, 2013
Length: 5 pages
To amend section 505 of the Federal Food, Drug, and Cosmetic Act to provide incentives for the development of new combination drugs.
The bill’s title was written by its sponsor.
This is the first step in the legislative process.
Reintroduced Bill — Introduced
This activity took place on a related bill, H.R. 406.
This is a House of Representatives bill in the United States Congress (indicated by the “H.R.” in “H.R. 2985”). A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
The committee chair determines whether a bill will move past the committee stage.
There have been no roll call votes related to this bill.
Click a format for a citation suggestion:
Civic Impulse. (2016). H.R. 2985 — 113th Congress: Combination Drug Development Incentive Act of 2013. Retrieved from https://www.govtrack.us/congress/bills/113/hr2985
“H.R. 2985 — 113th Congress: Combination Drug Development Incentive Act of 2013.” www.GovTrack.us. 2013. February 11, 2016 <https://www.govtrack.us/congress/bills/113/hr2985>
|title=H.R. 2985 (113th)
|accessdate=February 11, 2016
|author=113th Congress (2013)
|date=August 2, 2013
|quote=Combination Drug Development Incentive Act of 2013